A Finnish clinical imaging study shows that rest tremor in Parkinson's disease is not explained by greater dopamine loss. In ...
You can option the Tremor on more Super Duty pickups, while Platinum is added to Chassis Cabs.
For millions of Americans with essential tremor, simple tasks like writing a note, putting on makeup or plugging in an appliance can be difficult. In recent years, companies like Cala Health and ...
BOSTON--(BUSINESS WIRE)--Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...
Abstract: Deep Brain Stimulation (DBS) has emerged as an effective therapy for people suffering from medication refractory essential tremor (ET). Significant tremor suppression for patients can be ...
Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Encora X1™. This press ...
A new procedure at Henry Ford Health reduced most of the tremor in Jim Jones' right hand, making it easier for him to do his favorite hobby, woodworking. Jones, an Addison Township resident, said it ...
DETROIT (WXYZ) — For people living with tremors, even the smallest tasks can feel impossible: signing your name, buttoning a shirt, holding a drink without spilling ...
Propranolol and Primidone demonstrate efficacy in up to 70% of patients as first-line agents. MR-Guided Focused Ultrasound (MRgFUS) results in approximately 56% tremor reduction at 4 years. Deep Brain ...
Praxis Precision Medicines Inc. (NASDAQ: PRAX) stock rose Monday after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for ulixacaltamide for essential ...
GOING TO BE VERY MILD. I’LL HAVE THAT FOR YOU COMING UP. ALL RIGHT. THANKS, MO. A GROUNDBREAKING TREATMENT FOR PARKINSON’S AND TREMORS IS NOW AVAILABLE IN KENTUCKY. THE NORTON NEUROSCIENCE INSTITUTE ...
Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended stopping the Phase 3 studies. Praxis kept going. On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results